The performance of companies tied to Sildenafil's legacy presents a complex investment picture . While the initial surge generated substantial returns , generic competition have significantly diminished https://friendlybookmark.com/story21506298/copyright-s-flagship-product-and-pharma-a-speculative-opportunity